Bangalore, Apr 13, 2009: Dr. M. Vidyasagar, Executive Vice President, Tata Consultancy Services has been elected as the president of the Association for Biotechnology led enterprises (ABLE)- a national forum that represents the Indian Biotechnology Sector - at its third executive council meeting held at Bangalore recently.
The other office bearers who were elected to the executive council for the next three years include Mr. Mani Iyer, Executive Director, Intas Biopharmaceuticals Ltd. (Vice President), Ms. Anuradha Acharya, Managing Director, Ocimum Biosolutions Ltd. (Treasurer) and Dr. P.M.Murali, Managing Director, Evolva Biotech Pvt Ltd. (General Secretary).
The other members of the executive council are Ms. Kiran Mazumdar Shaw, CMD, Biocon Ltd. Dr. Rashmi H Barbhaiya , MD, Advinus Therapeutics Pvt. Ltd. Dr. Vijay Chandru , Chairman & CEO, Strand Life Sciences Pvt. Ltd. Mr. Nitin Deshmukh ,CEO, Private Equity, Kotak Mahindra Bank. Prof. Subba Rao, President R & D, Bigtec Pvt Ltd. Dr. K K Narayanan, Managing Director, Metahelix Life Sciences.Mr. Pramod Chaudhari, Chairman & Managing Director, Praj Industries, Mr. Sarath Naru, Managing Director, Ventureast Fund Advisors India Pvt Ltd.
Dr M Vidyasagar, President, ABLE said, "I feel honoured and happy to have been elected President of ABLE for the period 2009-12. The Indian biotechnology industry will play an increasingly major role on the global stage in years to come. Even in the current economic situation, the India cost advantage remains as compelling as ever. Going forward, India will be attractive not just for its low cost but also for its intellectual contributions."
|